Aarti Pharmalabs Ltd. Apl

Aarti Pharmalabs Limited – Powering Innovation. Delivering Excellence. Aarti Pharmalabs Limited (APL) is a global powerhouse in small-molecule Drug Substances CDMO services, trusted by leading Innovator Pharmaceutical and Biotech companies. We partner with our clients from first-in-human trial materials development through commercial-scale supply, leveraging exceptional scientific expertise, advanced infrastructure, and more than two decades of demonstrated excellence. At APL, we offer end-to-end development and manufacturing of RSMs, Intermediates and GMP APIs (NCE), with a strong focus on quality, speed, and regulatory compliance. Our diversified portfolio includes generic APIs, intermediates, xanthine derivatives, HPAPIs, corticosteroids, cytotoxic and oncology products, enabling us to support some of the most complex and high-value programs in the industry. With state-of-the-art R&D and globally accredited manufacturing facilities, inspected by USFDA, EU-GMP, EDQM, KFDA, COFEPRIS, and ANVISA, we ensure world-class compliance and dependable supply for customers across continents. Beyond pharmaceuticals, APL is also a preferred global partner in the Beverages and Nutraceuticals sectors, known for delivering unmatched quality in our flagship product, Synthetic Caffeine. Driven by innovation, powered by science, and committed to sustainability, APL is your strategic partner for building a healthier, more sustainable future.